A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Vanishing white matter (VWM; OMIM # 603896) is one of the most prevalent inherited childhood leukoencephalopathies. It has, however, become evident that VWM has a wider clinical spectrum, with age at onset inversely related to clinical severity. Many affected women experience a combination of leukoencephalopathy and primary amenorrhea or premature ovarian failure, a condition named ovarioleukodystrophy. Mutations in any of the genes encoding the 5 subunits of the Eukaryotic Initiation Factor 2B gene (EIF2B1, 2, 3, 4, and 5) can independently cause VWM.1
Footnotes
Study funding: Supported by grants from Monzino Foundation and Italian Ministry of Health (Ricerca Corrente and additional fund 5 × 1000 2008).
Author contributions: Dr. Laura Ghezzi: corresponding author, collected data, wrote the manuscript. Prof. Elio Scarpini: supervised the work. Dr. Mario Rango: supervised the manuscript. Dr. Andrea Arighi: collected data, wrote the manuscript. Dr. Maria Teresa Bassi: performed genetic analysis, supervised the work. Dr. Erika Tenderini: performed genetic analysis. Dr. Milena De Riz: supervised the work. Dr. Francesca Jacini: collected data. Dr. Giorgio G. Fumagalli: collected data. Dr. Anna M. Pietroboni: collected data. Dr. Daniela Galimberti: supervised the work. Prof. Nereo Bresolin: supervised the work.
Disclosure: The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
- Received April 16, 2012.
- Accepted July 16, 2012.
- © 2012 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Novel (ovario) leukodystrophy related to AARS2 mutationsCristina Dallabona, Daria Diodato, Sietske H. Kevelam et al.Neurology, May 07, 2014 -
Articles
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorderA. Vanderver, Y. Hathout, J. Maletkovic et al.Neurology, June 02, 2008 -
Clinical/Scientific Notes
PROGRESSIVE MEGALENCEPHALY DUE TO SPECIFIC EIF2Bε MUTATIONS IN TWO UNRELATED FAMILIESS. Passemard, A. Gelot, A. Fogli et al.Neurology, July 23, 2007 -
Clinical/Scientific Notes
ADULT-ONSET VANISHING WHITE MATTER LEUKOENCEPHALOPATHY PRESENTING AS PSYCHOSISC. Denier, A. Orgibet, F. Roffi et al.Neurology, April 30, 2007